Policy paper

Access Consortium statement on COVID-19 vaccines evidence

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 7 January 2021

Documents

Access Consortium statement on COVID-19 vaccines evidence

HTML

Details

This collective statement on COVID-19 vaccines builds on the Consortium바카라 사이트檚 May 2020 pledge to work together to counter the COVID-19 global pandemic. We have updated this pledge to include the newest member of the Consortium, the United Kingdom바카라 사이트檚 Medicines and Healthcare products Regulatory Agency (MHRA).

Access Consortium regulators pledge support to tackle COVID-19

Published 7 January 2021